1. GPCR/G Protein Neuronal Signaling
  2. mAChR GPR109A
  3. Mepenzolate bromide

Mepenzolate bromide is an orally administered muscarinic receptor antagonist with Kis of 0.68 and 2.6 nM for hM2R and hM3R, respectively. Mepenzolate bromide can be used to suppress the gastrointestinal hypermotility associated with irritable bowel syndrome.Mepenzolate bromide is a GPR109A inhibitor.

연구목적의 판매만을 진행합니다. 환자를 대상으로 한 판매는 하지 않습니다.

CAS No. : 76-90-4

사이즈 가격 재고 수량
Solid + Solvent (Highly Recommended)
10 mM * 1 mL in DMSO
ready for reconstitution
해외재고보유
Solution
10 mM * 1 mL in DMSO 해외재고보유
Solid
100 mg 해외재고보유
500 mg 해외재고보유
1 g   견적 받기  
5 g   견적 받기  

* 장바구니에 담기 전 물품의 수량을 선택해 주십시오.

This product is a controlled substance and not for sale in your territory.

고객리뷰

Based on 6 publication(s) in Google Scholar

Top Publications Citing Use of Products

    Mepenzolate bromide purchased from MedChemExpress. Usage Cited in: Brain Res Bull. 2025 Oct 22:232:111595.  [Abstract]

    Mepenzolate bromide (MPN) (5 mg/kg; i.p.; once daily). Behavior test analysis showed the immobility time of MPTP-induced PD mice in the TST and FST, and SPT results demonstrated the percentage of sucrose preference across experimental groups.

    Mepenzolate bromide purchased from MedChemExpress. Usage Cited in: Brain Res Bull. 2025 Oct 22:232:111595.  [Abstract]

    Mepenzolate bromide (MPN) (5 mg/kg; i.p.; once daily). mPFC immunoblots with quantification for IL-1β, IL-6, TNF-α, and GPR109A in MPTP-induced PD mice.

    Mepenzolate bromide purchased from MedChemExpress. Usage Cited in: Brain Res Bull. 2025 Oct 22:232:111595.  [Abstract]

    Mepenzolate bromide (MPN) (5 mg/kg; i.p.; once daily). mPFC immunofluorescence for GPR109A (red) and Iba1 (green) in MPTP-induced PD mice.

    Mepenzolate bromide purchased from MedChemExpress. Usage Cited in: Aging Cell. 2024 Aug 9:e14294.  [Abstract]

    Mepenzolate bromide (10 mg/kg; i.a.) rendered βOHB unable to reverse the damage caused by ACLT in OA rats.

    Mepenzolate bromide purchased from MedChemExpress. Usage Cited in: Aging Cell. 2024 Aug 9:e14294.  [Abstract]

    Mepenzolate bromide (10 mg/kg; i.a.) counteracted the pro-expression effects of βOHB on HCAR2 and p-AMPK in OA rats.

    View All mAChR Isoform Specific Products:

    • Biological Activity

    • 순도&문서

    • References

    • 고객리뷰

    제품 설명

    Mepenzolate bromide is an orally administered muscarinic receptor antagonist with Kis of 0.68 and 2.6 nM for hM2R and hM3R, respectively. Mepenzolate bromide can be used to suppress the gastrointestinal hypermotility associated with irritable bowel syndrome[1].Mepenzolate bromide is a GPR109A inhibitor[2].

    IC50 & Target

    mAChR[1]

    Cellular Effect
    Cell Line Type Value Description References
    HEK293 IC50
    64.9 μM
    Compound: Mepensolate
    Inhibition of 4-(4-(dimethylamino)styryl)-N-methylpyridinium uptake at human OCT1 expressed in HEK293 cells by confocal microscopy
    Inhibition of 4-(4-(dimethylamino)styryl)-N-methylpyridinium uptake at human OCT1 expressed in HEK293 cells by confocal microscopy
    [PMID: 18788725]
    In Vitro

    Mepenzolate not only exerts an anti-inflammatory effect via a muscarinic receptor-independent mechanism, but also a bronchodilatory effect via a muscarinic receptor-dependent mechanism. Mepenzolate is a subtype-non-specific muscarinic antagonist whose bronchodilatory effect and inhibitory effect on intestinal motility can be explained by its antagonistic action on M3R[1].

    MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

    In Vivo

    Mepenzolate bromide, a GPR109A receptor blocker, abolishes the beneficial effects of niacin on body weight, colon wet weight as well as colonic levels of myeloperoxidase (MPO) and VEGF[2].
    Mepenzolate bromide is a muscarinic antagonist. Intratracheal administration or inhalation of Mepenzolate bromide decreases the severity of elastase-induced airspace enlargement and respiratory dysfunction. Mepenzolate bromide may be an effective therapeutic for the treatment of chronic obstructive pulmonary disease (COPD) due to its anti-inflammatory and bronchodilatory activities[3].

    MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

    Animal Model: Adult male Wistar rats, weighing 150-200 g[2]
    Dosage: 5  mg/kg
    Administration: Intraperitoneal injection
    Result: Abolished the protective effect of niacin against iodoacetamide-induced rise in colon wet weight as well as the colonic levels of both MPO and VEGF.
    Animal Model: ICR mice (4-6 weeks old, male) and DBA/2 mice (5 weeks old, female)[3]
    Dosage: 0.04, 0.38, 3.8, 38 μg/kg; 45.2 and 226 μg per chamber
    Administration: "0.04, 0.38, 3.8, 38 μg/kg administered intratracheally once daily for 14 days
    45.2 and 226 μg per chamber by inhalation once daily for 14 days"
    Result: The simultaneous daily intratracheal administration suppressed this enlargement in a dose-dependent manner.
    The inhalation route was similar to those observed with the intratracheal mode of administration.
    분자량

    420.34

    화학식

    C21H26BrNO3

    CAS No.
    Appearance

    Solid

    Color

    White to off-white

    SMILES

    C[N+]1(C)CC(OC(C(C2=CC=CC=C2)(O)C3=CC=CC=C3)=O)CCC1.[Br-]

    선적

    Room temperature in continental US; may vary elsewhere.

    보관

    4°C, sealed storage, away from moisture

    *In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)

    용액&용해도
    In Vitro: 

    DMSO : 175 mg/mL (416.33 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)

    H2O : 10 mg/mL (23.79 mM; ultrasonic and warming and heat to 60°C)

    Preparing
    Stock Solutions
    Concentration Solvent Mass 1 mg 5 mg 10 mg
    1 mM 2.3790 mL 11.8951 mL 23.7903 mL
    5 mM 0.4758 mL 2.3790 mL 4.7581 mL
    View the Complete Stock Solution Preparation Table

    * Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
    Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.

    * Note: If you choose water as the stock solution, please dilute it to the working solution, then filter and sterilize it with a 0.22 μm filter before use.

    • 몰농도 계산기

    • 농도 희석 계산기

    Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

    Mass
    =
    Concentration
    ×
    Volume
    ×
    Molecular Weight *

    Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

    This equation is commonly abbreviated as: C1V1 = C2V2

    Concentration (start)

    C1

    ×
    Volume (start)

    V1

    =
    Concentration (final)

    C2

    ×
    Volume (final)

    V2

    In Vivo:

    Select the appropriate dissolution method based on your experimental animal and administration route.

    For the following dissolution methods, please ensure to first prepare a clear stock solution using an In Vitro approach and then sequentially add co-solvents:
    To ensure reliable experimental results, the clarified stock solution can be appropriately stored based on storage conditions. As for the working solution for in vivo experiments, it is recommended to prepare freshly and use it on the same day.
    The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.

    • Protocol 1

      Add each solvent one by one:  10% DMSO    40% PEG300    5% Tween-80    45% Saline

      Solubility: ≥ 2.08 mg/mL (4.95 mM); Clear solution

      This protocol yields a clear solution of ≥ 2.08 mg/mL (saturation unknown).

      Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (20.8 mg/mL) to 400 μL PEG300, and mix evenly; then add 50 μL Tween-80 and mix evenly; then add 450 μL Saline to adjust the volume to 1 mL.

      Preparation of Saline: Dissolve 0.9 g sodium chloride in ddH₂O and dilute to 100 mL to obtain a clear Saline solution.
    • Protocol 2

      Add each solvent one by one:  10% DMSO    90% (20% SBE-β-CD in Saline)

      Solubility: ≥ 2.08 mg/mL (4.95 mM); Clear solution

      This protocol yields a clear solution of ≥ 2.08 mg/mL (saturation unknown).

      Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (20.8 mg/mL) to 900 μL 20% SBE-β-CD in Saline, and mix evenly.

      Preparation of 20% SBE-β-CD in Saline (4°C, storage for one week): 2 g SBE-β-CD powder is dissolved in 10 mL Saline, completely dissolve until clear.

    For the following dissolution methods, please prepare the working solution directly. It is recommended to prepare fresh solutions and use them promptly within a short period of time.
    The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.

    • Protocol 1

      Add each solvent one by one:  Saline

      Solubility: 10 mg/mL (23.79 mM); Clear solution; Need ultrasonic and warming and heat to 60°C

    In Vivo Dissolution Calculator
    Please enter the basic information of animal experiments:

    Dosage

    mg/kg

    Animal weight
    (per animal)

    g

    Dosing volume
    (per animal)

    μL

    Number of animals

    Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.
    Please enter your animal formula composition:
    %
    DMSO +
    +
    %
    Tween-80 +
    %
    Saline
    Recommended: Keep the proportion of DMSO in working solution below 2% if your animal is weak.
    The co-solvents required include: DMSO, . All of co-solvents are available by MedChemExpress (MCE). , Tween 80. All of co-solvents are available by MedChemExpress (MCE).
    Calculation results:
    Working solution concentration: mg/mL
    Method for preparing stock solution: mg drug dissolved in μL  DMSO (Stock solution concentration: mg/mL).

    *In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)

    The concentration of the stock solution you require exceeds the measured solubility. The following solution is for reference only. If necessary, please contact MedChemExpress (MCE).
    Method for preparing in vivo working solution for animal experiments: Take μL DMSO stock solution, add μL . μL , mix evenly, next add μL Tween 80, mix evenly, then add μL Saline.
     If the continuous dosing period exceeds half a month, please choose this protocol carefully.
    Please ensure that the stock solution in the first step is dissolved to a clear state, and add co-solvents in sequence. You can use ultrasonic heating (ultrasonic cleaner, recommended frequency 20-40 kHz), vortexing, etc. to assist dissolution.
    순도&문서

    Purity: 99.91%

    References

    Complete Stock Solution Preparation Table

    * Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
    Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.

    Optional Solvent Concentration Solvent Mass 1 mg 5 mg 10 mg 25 mg
    H2O / DMSO 1 mM 2.3790 mL 11.8951 mL 23.7903 mL 59.4757 mL
    5 mM 0.4758 mL 2.3790 mL 4.7581 mL 11.8951 mL
    10 mM 0.2379 mL 1.1895 mL 2.3790 mL 5.9476 mL
    15 mM 0.1586 mL 0.7930 mL 1.5860 mL 3.9650 mL
    20 mM 0.1190 mL 0.5948 mL 1.1895 mL 2.9738 mL
    DMSO 25 mM 0.0952 mL 0.4758 mL 0.9516 mL 2.3790 mL
    30 mM 0.0793 mL 0.3965 mL 0.7930 mL 1.9825 mL
    40 mM 0.0595 mL 0.2974 mL 0.5948 mL 1.4869 mL
    50 mM 0.0476 mL 0.2379 mL 0.4758 mL 1.1895 mL
    60 mM 0.0397 mL 0.1983 mL 0.3965 mL 0.9913 mL
    80 mM 0.0297 mL 0.1487 mL 0.2974 mL 0.7434 mL
    100 mM 0.0238 mL 0.1190 mL 0.2379 mL 0.5948 mL

    * Note: If you choose water as the stock solution, please dilute it to the working solution, then filter and sterilize it with a 0.22 μm filter before use.

    • No file chosen (Maximum size is: 1024 Kb)
    • If you have published this work, please enter the PubMed ID.
    • Your name will appear on the site.
    Help & FAQs
    • Do most proteins show cross-species activity?

      Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

    최근 본 상품:

    온라인 문의

    Your information is safe with us. * Required Fields.

    상품명

     

    Requested Quantity *

    고객명 *

     

    호칭

    메일주소 *

     

    전화번호 *

    Department

     

    회사명 *

    City

    Country or Region *

         

    비고

    대량구매 문의

    Inquiry Information

    상품명:
    Mepenzolate bromide
    Cat. No.:
    HY-17585
    수량:
    MCE Japan Authorized Agent: